NAGS and metabolic dysfunction-associated steatotic liver disease: The results from our hepatic gene expression analysis indirectly suggest that MASLD severity may be associated with a greater liberation of ammonia from glutamine (higher GLS1 expression), reduced activation of the urea cycle (lower NAGS expression) as well as a recapture of ammonia (higher GLUL expression) (Figure 7).